2000
- NEOPHARM foundedCompany established on July 1, 2000
- ATOPALM launchedLaunch of ATOPALM, a skincare brand for sensitive skin (December)
Overview
Since its founding in 2000, NEOPHARM has researched and developed solutions for sensitive skin based on its proprietary MLE® skin-barrier technology.
2000
Founded
5
Brands
40+
Countries
170+
Patents & Papers
| Company | NEOPHARM Co., Ltd. |
|---|---|
| CEO | Kim Yang Soo |
| Founded | July 1, 2000 |
| Headquarters | 309-8 Techno 2-ro, Yuseong-gu, Daejeon, Republic of Korea |
| Business | R&D, manufacturing and sales of derma-cosmetics |
| Listing | KOSDAQ (092730) |
| Key Brands | ATOPALM, REALBARRIER, ZEROID, DERMA:B, T'ELSE |

Vision
“Good Skin, Good Life” — healthy skin for a healthy life.
Our philosophy is to create everyday beauty and balance through skin-barrier science and dermatological research — supporting healthy-looking skin and everyday well-being.
We address skin concerns with science-based skincare solutions
We continue to advance our proprietary technology that mimics the multi-lamellar structure of the skin barrier
We strengthen our competitiveness worldwide through exports to 40+ countries and global partnerships
History
Key milestones since our founding in 2000, as we have developed solutions for sensitive skin through skin-barrier technology.
2000
2001
2002
2005
2007
2009
2011
2013
2015
2017
2022
2023
2024
2025
Ethics
01
We support everyday skincare needs with science-based, thoughtfully developed products.
02
We uphold fairness and transparency and build partnerships based on mutual respect.
03
We value diversity and creativity and support a healthy work environment.
04
We work to reduce environmental impact through product development and contribute to our communities.
Corporate Identity

Global Presence
Built on our proprietary MLE® technology, NEOPHARM exports its products to more than 40 countries worldwide.
40+
Export Markets
40%
Overseas Sales
5
Brands
Regional
HQ
Daejeon Headquarters & CRID Center
ASIA
China, Japan, Hong Kong, Taiwan, India
SEA
E-commerce-led expansion
NA
Available through Amazon, Target, and more
EU
Expanding distribution across Western and Eastern Europe
CIS
Distribution of ATOPALM and REALBARRIER
Brand × Market
| ATOPALM | USA, China, Russia, Southeast Asia, Middle East, Europe |
|---|---|
| REALBARRIER | USA, Japan, China, Europe, Southeast Asia, Australia |
| ZEROID | China, Southeast Asia, Middle East, Russia, India |
| DERMA:B | Japan, Southeast Asia, Australia, USA, Europe |
| T'else | Korea, China, Southeast Asia |
Global Inquiry
For global marketing partnerships and overseas B2B sales, please contact the channels below.
Global Marketing
Inquiries about overseas marketing, brand collaborations, and global campaigns.
globalmarketing@neopharm.co.krOverseas B2B
Inquiries about overseas distribution and exports, B2B partnerships, and retail listing proposals.
overseas_b2b@neopharm.co.krContact